Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Cancer Diagnostics Market


6. Market Share – Global Cancer Diagnostics Analysis

6.1 By Application
6.2 By Test Type
6.3 By EndUsers
6.4 By Country


7. Application – Global Cancer Diagnostics Market

7.1 Breast Cancer
7.2 Colorectal Cancer
7.3 Cervical Cancer
7.4 Lung Cancer
7.5 Prostate Cancer
7.6 Skin Cancer
7.7 Blood Cancer
7.8 Kidney Cancer
7.9 Liver Cancer
7.10 Pancreatic Cancer
7.11 Ovarian Cancer
7.12 Others


8. Test Type – Global Cancer Diagnostics Market

8.1 Tumor Biomarkers Tests
8.2 Imaging
8.3 Biopsy
8.4 Liquid Biopsy
8.5 Immunohistochemistry
8.6 In Situ Hybridization


9. End-User – Global Cancer Diagnostics Market

9.1 Diagnostic Centers
9.2 Hospitals and Clinics
9.3 Research Institutes
9.4 Others


10. Country – Global Cancer Diagnostics Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis – Global Cancer Diagnostics Market

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis – Global Cancer Diagnostics Market

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis – Global Cancer Diagnostics Market

13.1 llumina

13.1.1 Overviews
13.1.2 Recent Developments
13.1.3 Revenues

13.2 Abbott Laboratories

13.2.1 Overviews
13.2.2 Recent Developments
13.2.3 Revenues

13.3 Thermo Fisher Scientific, Inc

13.3.1 Overviews
13.3.2 Recent Developments
13.3.3 Revenues

13.4 QIAGEN N.V.

13.4.1 Overviews
13.4.2 Recent Developments
13.4.3 Revenues

13.5 Roche Holding AG.

13.5.1 Overviews
13.5.2 Recent Developments
13.5.3 Revenues

13.6 Pfizer, Inc.

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Financial Insights

13.7 Koninklijke Philips N.V.

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Financial Insights

13.8 bioM?rieux

13.8.1 Overview
13.8.2 Recent Development
13.8.3 Financial Insights



List of Figures

Figure-01: Global – Cancer Diagnostics Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Cancer Diagnostics Market (Billion US$), 2024 – 2030
Figure-03: Application – Breast Cancer Market (Million US$), 2019 – 2023
Figure-04: Application – Forecast for Breast Cancer Market (Million US$), 2024 – 2030
Figure-05: Application – Colorectal Cancer Market (Million US$), 2019 – 2023
Figure-06: Application – Forecast for Colorectal Cancer Market (Million US$), 2024 – 2030
Figure-07: Application – Cervical Cancer Market (Million US$), 2019 – 2023
Figure-08: Application – Forecast for Cervical Cancer Market (Million US$), 2024 – 2030
Figure-09: Application – Lung Cancer Market (Million US$), 2019 – 2023
Figure-10: Application – Forecast for Lung Cancer Market (Million US$), 2024 – 2030
Figure-11: Application – Prostate Cancer Market (Million US$), 2019 – 2023
Figure-12: Application – Forecast for Prostate Cancer Market (Million US$), 2024 – 2030
Figure-13: Application – Skin Cancer Market (Million US$), 2019 – 2023
Figure-14: Application – Forecast for Skin Cancer Market (Million US$), 2024 – 2030
Figure-15: Application – Blood Cancer Market (Million US$), 2019 – 2023
Figure-16: Application – Forecast for Blood Cancer Market (Million US$), 2024 – 2030
Figure-17: Application – Kidney Cancer Market (Million US$), 2019 – 2023
Figure-18: Application – Forecast for Kidney Cancer Market (Million US$), 2024 – 2030
Figure-19: Application – Liver Cancer Market (Million US$), 2019 – 2023
Figure-20: Application – Forecast for Liver Cancer Market (Million US$), 2024 – 2030
Figure-21: Application – Pancreatic Cancer Market (Million US$), 2019 – 2023
Figure-22: Application – Forecast for Pancreatic Cancer Market (Million US$), 2024 – 2030
Figure-23: Application – Ovarian Cancer Market (Million US$), 2019 – 2023
Figure-24: Application – Forecast for Ovarian Cancer Market (Million US$), 2024 – 2030
Figure-25: Application – Others Market (Million US$), 2019 – 2023
Figure-26: Application – Forecast for Others Market (Million US$), 2024 – 2030
Figure-27: Test Type – Tumor Biomarkers Tests Market (Million US$), 2019 – 2023
Figure-28: Test Type – Forecast for Tumor Biomarkers Tests Market (Million US$), 2024 – 2030
Figure-29: Test Type – Imaging Market (Million US$), 2019 – 2023
Figure-30: Test Type – Forecast for Imaging Market (Million US$), 2024 – 2030
Figure-31: Test Type – Biopsy Market (Million US$), 2019 – 2023
Figure-32: Test Type – Forecast for Biopsy Market (Million US$), 2024 – 2030
Figure-33: Test Type – Liquid Biopsy Market (Million US$), 2019 – 2023
Figure-34: Test Type – Forecast for Liquid Biopsy Market (Million US$), 2024 – 2030
Figure-35: Test Type – Immunohistochemistry Market (Million US$), 2019 – 2023
Figure-36: Test Type – Forecast for Immunohistochemistry Market (Million US$), 2024 – 2030
Figure-37: Test Type – In Situ Hybridization Market (Million US$), 2019 – 2023
Figure-38: Test Type – Forecast for In Situ Hybridization Market (Million US$), 2024 – 2030
Figure-39: End-User – Diagnostic Centers Market (Million US$), 2019 – 2023
Figure-40: End-User – Forecast for Diagnostic Centers Market (Million US$), 2024 – 2030
Figure-41: End-User – Hospitals and Clinics Market (Million US$), 2019 – 2023
Figure-42: End-User – Forecast for Hospitals and Clinics Market (Million US$), 2024 – 2030
Figure-43: End-User – Research Institutes Market (Million US$), 2019 – 2023
Figure-44: End-User – Forecast for Research Institutes Market (Million US$), 2024 – 2030
Figure-45: End-User – Others Market (Million US$), 2019 – 2023
Figure-46: End-User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-47: United States – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-48: United States – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-49: Canada – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-50: Canada – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-51: France – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-52: France – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-53: Germany – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-54: Germany – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-55: Italy – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-56: Italy – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-57: Spain – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-58: Spain – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-59: United Kingdom – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-60: United Kingdom – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-61: Belgium – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-62: Belgium – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-63: Netherlands – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-64: Netherlands – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-65: Turkey – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-66: Turkey – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-67: China – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-68: China – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-69: Japan – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-70: Japan – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-71: India – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-72: India – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-73: South Korea – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-74: South Korea – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-75: Thailand – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-76: Thailand – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-77: Malaysia – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-78: Malaysia – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-79: Indonesia – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-80: Indonesia – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-81: Australia – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-82: Australia – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-83: New Zealand – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-84: New Zealand – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-85: Brazil – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-86: Brazil – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-87: Mexico – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-88: Mexico – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-89: Argentina – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-90: Argentina – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-91: Saudi Arabia – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-92: Saudi Arabia – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-93: UAE – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-94: UAE – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-95: South Africa – Cancer Diagnostics Market (Million US$), 2019 – 2023
Figure-96: South Africa – Forecast for Cancer Diagnostics Market (Million US$), 2024 – 2030
Figure-97: llumina – Global Revenue (Million US$), 2019 – 2023
Figure-98: llumina – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-99: Abbott Laboratories – Global Revenue (Million US$), 2019 – 2023
Figure-100: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-101: Thermo Fisher Scientific, Inc – Global Revenue (Million US$), 2019 – 2023
Figure-102: Thermo Fisher Scientific, Inc – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-103: QIAGEN N.V. – Global Revenue (Million US$), 2019 – 2023
Figure-104: QIAGEN N.V. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-105: Roche Holding AG. – Global Revenue (Million US$), 2019 – 2023
Figure-106: Roche Holding AG. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-107: Pfizer, Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-108: Pfizer, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-109: Koninklijke Philips N.V. – Global Revenue (Million US$), 2019 – 2023
Figure-110: Koninklijke Philips N.V. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-111: bioM?rieux – Global Revenue (Million US$), 2019 – 2023
Figure-112: bioM?rieux – Forecast for Global Revenue (Million US$), 2024 – 2030

List of Tables

Table-01: Global – Cancer Diagnostics Market Share by Application (Percent), 2019 – 2023
Table-02: Global – Forecast for Global Cancer Diagnostics Market Share by Application (Percent), 2024 – 2030
Table-03: Global – Cancer Diagnostics Market Share by Test Type (Percent), 2019 – 2023
Table-04: Global – Forecast for Global Cancer Diagnostics Market Share by Test Type (Percent), 2024 – 2030
Table-05: Global – Cancer Diagnostics Market Share by End User (Percent), 2019 – 2023
Table-06: Global – Forecast for Global Cancer Diagnostics Market Share by End User (Percent), 2024 – 2030
Table-07: Global – Cancer Diagnostics Market Share by Countries (Percent), 2019 – 2023
Table-08: Global – Forecast for Global Cancer Diagnostics Market Share by Countries (Percent), 2024 – 2030